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Abstract Recent progress has been made in the production
of higher alcohols by harnessing the power of natural
amino acid biosynthetic pathways. Here, we describe the
first strain of Escherichia coli developed to produce the
higher alcohol and potential new biofuel 2-methyl-1-
butanol (2MB). To accomplish this, we explored the
biodiversity of enzymes catalyzing key parts of the
isoleucine biosynthetic pathway, finding that AHAS II
(ilvGM) from Salmonella typhimurium and threonine
deaminase (ilvA) from Corynebacterium glutamicum im-
prove 2MB production the most. Overexpression of the
native threonine biosynthetic operon (thrABC) on plasmid
without the native transcription regulation also improved
2MB production in E. coli. Finally, we knocked out
competing pathways upstream of threonine production
(ΔmetA, Δtdh) to increase its availability for further
improvement of 2MB production. This work led to a strain
of E. coli that produces 1.25 g/L 2MB in 24 h, a total
alcohol content of 3 g/L, and with yields of up to 0.17 g
2MB/g glucose.
Keywords Metabolic engineering . Biofuel .E. coli
Introduction
As the global demand for energy continues to rise, biofuels
derived from renewable sources have become increasingly
important. Currently, most of the emphasis in biofuels is on
bio-ethanol as there is a long history for its production
(Chandrakant and Bisaria 1998; Galbe and Zacchi 2002;
Jarboe et al. 2007). However, increasing attention is being
paid to higher alcohols (Miller et al. 1981; Atsumi et al.
2007, 2008) as the potential for a direct replacement of
gasoline. Those alcohols have four to five carbons and
possess a host of qualities making them more suitable as a
liquid fuel than ethanol, including lower vapor pressure,
lower hygroscopicity, and higher energy density.
Since the gasoline we use today consists of a finely
tuned mixture of components, it is likely that the next-
generation fuel to replace gasoline will also be a mixture
and the five carbon alcohol 2-methyl-1-butanol (2MB), also
known as active amyl alcohol, is likely to be an important
component. Previously, 2MB has been considered a minor
byproduct found in beer, wine, and other fermented
beverages. This is due to the presence of several pyruvate
decarboxylase (PDC) enzymes found in the yeast, Saccha-
romyces cerevisiae, used to ferment these alcoholic bev-
erages, some of which are able to catalyze the
decarboxylation of 2-ketoacids larger than pyruvate, espe-
cially those 2-ketoacids involved in branched-chain amino
acid synthesis (Dickinson et al. 1997, 1998, 2000). PDC
converts these 2-ketoacids into aldehydes, which are then
reduced to alcohols in one further step using an alcohol
dehydrogenase (ADH) enzyme. Until recently (Atsumi et
al. 2008), the utility of these higher alcohols as biofuels has
not been fully realized. No report has demonstrated the
overproduction of 2MB from glucose in a microorganism.
The production of higher alcohols from amino acid
precursors in Escherichia coli has proven to be promising
(Atsumi et al. 2008; Shen and Liao 2008; Connor and Liao
2008). Because it exploits the host’s native amino acid
synthesis pathways, this approach can be implemented in a
variety of hosts to produce the desired products. The
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biosynthetic pathways of the branched-chain amino acids
produce at least four natural 2-ketoacids that can be
converted to potentially useful higher alcohols (Atsumi et
al. 2008). Here, we utilize the isoleucine biosynthetic
pathway in particular to synthesize 2-keto-3-methylvalerate
(KMV), which is then converted to 2MB via a promiscuous
2-ketoacid decarboxylase (KDC) and ADH (Fig. 1).
In E. coli, KMV is derived from threonine, which in turn
is part of the aspartate family of amino acids. The
production of KMV from glucose involves ten enzymatic
reactions from the glycolytic product phosphoenolpyruvate
(PEP). From PEP, aspartate is produced from the products
of two genes, ppc and aspC (Fig. 1). Only four genes, asd
and the thrABC operon, are required to complete the five
reactions to produce threonine from aspartate. The deam-
ination of threonine to 2-ketobutyrate (2KB) can be
catalyzed by the products of either one of two genes, ilvA
and tdcB, encoding a biosynthetic and catabolic threonine
deaminase, respectively. The condensation of 2KB and
pyruvate to 2-aceto-2-hydroxybutyrate is catalyzed by
acetohydroxy acid synthase (AHAS), an enzyme which
also catalyzes the first step in valine production. Two more
genes, ilvC and ilvD, are necessary for the formation of
KMV, the penultimate precursor in 2MB synthesis. In the
cell, KMV is normally converted to isoleucine with
transamination carried out by transaminase B encoded by
ilvE.
With the utilization of the isoleucine production pathway
in the formation of 2MB, there is a lot of previous work to
draw upon on the overproduction of isoleucine in various
organisms. It has been shown that overexpression of ilvD is
important to prevent the buildup of 2,3-dihydroxy-3-
methylvalerate (Hashiguchi et al. 1999), the immediate
precursor to KMV. For the condensation of 2KB and
pyruvate, there are multiple AHAS enzymes to consider,
three in E. coli alone, but each has slightly different
properties making it more conducive for either valine or
isoleucine production, of which we of course prefer the
latter. Of the three isozymes found in E. coli, AHAS II
encoded by ilvGM would likely be the best for isoleucine
production were it not for a frameshift mutation rendering it
inactive in K-12-derived strains (Favre et al. 1976).
Nonetheless, enzyme kinetic data show that AHAS II from
E. coli and several other enteric bacteria provides a greater
ratio of 2-aceto-2-hydroxybutryate to 2-acetolactate forma-
tion than the other AHAS isozymes (Barak et al. 1987;
Gollop et al. 1990), suggesting that AHAS II should be the
best isozyme for isoleucine production. In research on
Corynebacterium glutamicum, it was shown that a lysine-
producing strain could be converted to isoleucine produc-
tion with the overexpression of only three key genes: a
feedback resistant hom (equivalent to thrA in E. coli), thrB,
and feedback resistant ilvA (Morbach et al. 1996). Over-


































































Fig. 1 Pathway for 2-methyl-1-
butanol synthesis and important
side products. Genes in bold are
overexpressed in our system
while underlined genes are
knocked out. PEP phospho-
enolpyruvate, KIV keto-isoval-
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from lysine production (Fig. 1), while overexpression of
thrB draws carbon flux away from methionine. The third
gene, ilvA, allows for the deamination of threonine to 2KB,
thus feeding the AHAS enzymatic reaction.
On the basis of the prior art, this article reports the
construction of an E. coli strain to produce 2MB from
glucose. This work presents additional challenges since
byproducts such as 1-propanol and isobutanol are also
produced from the KDC and ADH used to produce 2MB.
Furthermore, these products are toxic to the cell when
present in sufficient concentrations.
Materials and methods
Bacterial strains
E. coli BW25113 (rrnBT14 ΔlacZWJ16 hsdR514
ΔaraBADAH33 ΔrhaBADLD78) was designated as the
wild-type strain (Datsenko and Wanner 2000) for this study.
XL-1 Blue (Stratagene, La Jolla, CA, USA) was used to
propagate all plasmids. Construction of strains CRS22 and
CRS24 is described previously (Shen and Liao 2008). Strain
CRS38 was constructed by deleting the leuABCD operon as
previously described (Datsenko and Wanner 2000). Host
gene deletions of leuA and ilvE in strains AFC16 and
AFC18, respectively, were achieved with P1 transduction
using the appropriate Keio collection strains (Baba et al.
2006) as donors. The KanR inserted into the target gene
region was removed using pCP20 (Datsenko and Wanner
2000) in between each consecutive knockout. The removal
of each gene segment was verified by colony polymerase
chain reaction (PCR) using the appropriate primers.
Reagents, media, and cultivation
All restriction enzymes and Antarctic phosphatase were
purchased from New England Biolabs (Ipswich, MA,
USA). The Rapid DNA ligation kit was supplied by Roche
(Manheim, Germany). KOD DNA polymerase was pur-
chased from EMD Chemicals (San Diego, CA, USA).
Oligonucleotides were ordered from Invitrogen (Carlsbad,
CA, USA).
For all production experiments, strains were grown in a
modified M9 medium (6 g Na2HPO4, 3 g KH2PO4, 1 g
NH4Cl, 0.5 g NaCl, 1 mM MgSO4, 1 mM CaCl2, 10 mg
vitamin B1 per liter of water) containing 15 g/L of glucose,
5 g/L of yeast extract, and 1,000× Trace Metals Mix A5
(2.86 g H3BO3, 1.81 g MnCl2·4H2O, 0.222 g ZnSO4·7H2O,
0.39 g Na2MoO4·2H2O, 79 mg CuSO4·5H2O, 49.4 mg Co
(NO3)2·6H2O per liter of water). From 2 mL overnight
cultures grown in LB, cultures were inoculated at 1% into
10 mL of the above modified M9 medium and were
allowed to grow at 37°C in 250 mL baffled flasks to an
OD600 of approximately 0.6 before induction with 0.1 mM
IPTG. After induction, 5 mL of the cultures was transferred
to 125 mL screw-cap flasks and the incubation temperature
was reduced to 30°C. For the experiments where L-
threonine or 2-ketobutyrate was added to the culture, it
was added at induction to a final concentration of 8 g/L.
Antibiotics were added as necessary for plasmid mainte-
nance (ampicillin 100 μg/mL, kanamycin 50 μg/mL, and
spectinomycin 50 μg/mL). All antibiotics and reagents
were purchased from either Sigma-Aldrich (St. Louis, MO,
USA) or Fisher Scientific (Houston, TX, USA).
Plasmid construction
The vectors pSA40, pSA54, pSA55 (Atsumi et al. 2008),
and pCS49 (Shen and Liao 2008) were designed and
constructed as described previously. The vectors expressing
the various AHAS genes were built in a manner similar to
pSA54, all beginning with pSA40 as the base.
Vector pKS15 began by amplifying the ilvBN genes from
the E. coli MG1655 chromosome using primers IlvB-
Acc65I-fwd and IlvNC-SOE1. The beginning of the ilvC
gene located on pSA54 was also amplified from the SalI site
upstream of the RBS to the Acc65I site within the ilvC gene
using primers IlvNC-SOE2 and IlvC-Acc65I-rev. These two
fragments were then joined by splice overlap extension
(SOE), creating a ilvBNC* fragment with Acc65I cut sites at
either end. Then pSA54 was cut with Acc65I, the large
portion was gel purified, and then this backbone was ligated
with the new ilvBNC* fragment to create pKS15.
In order to test the expression of the protein encoded by
E. coli ilvG, we needed to fix the frameshift present at base
pair 984 in the ilvG gene found in E. coli MG1655. The
sequence at the frameshift indicates a TGA stop codon
within the ilvG reading frame, and this sequence was
modified from 5′-AATCAATGACTGGCA-3′ to 5′-AAT
CAATGTGACTGGCA-3′ to recover expression of this
protein. To accomplish this feat, we amplified two frag-
ments of the genome with primers IlvG-Acc65I-fwd and
TGins-SapI-rev for the beginning portion of the ilvG gene
and primers TGins-SapI-fwd and IlvM-HindIII-rev for the
end portion of ilvGM. These fragments along with pSA40
were digested with Acc65I, HindIII, and SapI as appropriate
and then ligated together to create pAFC22. To complete
vector pAFC23, the backbone of pSA54 was amplified
from the ilvC gene to the p15A origin of replication using
primers IlvC-SA-BamHI-fwd and P15-SA-SacI-rev. This
backbone was ligated to the SacI–BamHI fragment from
pAFC22 containing the kanamycin resistance gene and
ilvGM genes to create pAFC23.
Vectors pAFC3 and pAFC29 each began by using
primers IlvG-Acc65I-fwd and IlvM-HindIII-rev to amplify
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the ilvGM genes from the chromosomes of Salmonella
typhimurium LT2 and Klebsiella pneumoniae ATCC
700721, respectively, creating an Acc65I–HindIII fragment.
These fragments were then ligated in the same cut sites of
pSA40. From here we added the ilvCD genes and P15A
replication origin from pSA54 in the same fashion was used
for pAFC23.
Vector pAFC26 began by using primers CG-ilvB-ClaI-
fwd and CG-ilvN-BamHI-rev to amplify the ilvBN genes
from the chromosome of C. glutamicum ATCC 13032 to
make a ClaI–BamHI fragment. Ligation of this fragment
into the same cut sites of pSA40 introduced a new RBS
downstream of the one already present. Similar to the
previous three vectors, the ilvCD genes and P15A origin
were added to complete this vector.
The vectors expressing the various threonine deaminase
genes all used pSA55 as a base. From the E. coli MG1655
chromosome, tdcB (pAFC8) and ilvA (pAFC45) were
amplified using primers TdcB-XbaI-fwd/rev and IlvA-
XbaI-fwd/rev, respectively. From the C. glutamicum chro-
mosome ilvA (pAFC46) was amplified using primers
CG-ilvA-XbaI-fwd/rev. Amplification of each of these three
genes resulted in DNA fragments with XbaI cut sites at
each end. These fragments were then ligated into the XbaI
cut site directly behind the ADH2 gene on pSA55 and
orientation was confirmed by PCR and by restriction digest.
All vectors were sequenced using the appropriate
primers to verify sequence fidelity.
Metabolite detection
The produced alcohol compounds were quantified by a gas
chromatograph (GC) equipped with flame ionization
detector (FID). The system consisted of model 5890A GC
(Hewlett Packard, Avondale, PA, USA) and a model 7673A
automatic injector, sampler and controller (Hewlett Pack-
ard). The separation of alcohol compounds was carried out
by A DB-WAX capillary column (30 m, 0.32 mm-i.d.,
0.50 μm film thickness) purchased from Agilent Technol-
ogies (Santa Clara, CA, USA). GC oven temperature was
initially held at 40°C for 2 min and raised with a gradient of
5°C/min for 1 min, then held at 45°C for 4 min, then raised
again with a gradient of 15°C/min until 190°C. At this
point, the temperature was raised with a gradient 50°C/min
until 230°C and held for 4 min to clear the column of any
remaining chemicals. Helium was used as the carrier gas
with 9.0 psi inlet pressure. The FID was fed by a mixture of
hydrogen, air, and helium. The injector and detector were
maintained at 225°C. The column was injected with 0.5 μL
of the supernatant of culture broth in a split injection mode
with a 1:15 split ratio. The internal standard used was 1-
pentanol, and alcohol content was determined by extrapo-




Our lab has previously shown 2MB formation from glucose
in E. coli (Atsumi et al. 2008). In order to increase 2MB
production, it was important to first overexpress the
enzymes that would boost its production. The first
committed reaction in 2MB synthesis is the condensation
of 2KB and pyruvate to form 2-aceto-2-hydroxybutyrate.
As this reaction can be catalyzed by several different types
of AHAS enzyme, we compared a number of these AHAS
(Table 1) to select one most suitable for 2MB production.
To test the efficacy of these AHAS isozymes, we
replaced ilvIH from pSA54 with other genes encoding
AHAS (Table 2) in a cassette fashion to ensure that each
enzyme would be expressed similarly. We combined these
AHAS plasmids with pSA55, which expresses the KDC
and ADH necessary to convert KMV from the isoleucine
pathway into 2MB, in a BW25113 host. Since the KDC
Table 1 Comparison of AHAS specificity for 2KB in synthesis of 2MB
Isozyme Genes Organism 2-Methyl-1-butanol 1-Propanol Total alcohol conversiona (%)
Titer (mM) Conversiona (%) Titer (mM) Conversiona (%)
AHAS III ilvIH E. coli 22.4±0.8 29 33.3±5.0 43 71
AHAS II ilvGM E. coli 24.0±2.5 31 38.2±3.4 49 79
S. typhimurium 36.7±0.2 47 30.0±0.9 38 85
K. pneumoniae 26.9±0.1 34 35.4±0.5 45 80
AHAS I ilvBN E. coli 1.29±0.69 1.6 47.5±5.0 61 62
C. glutamicum 13.1±3.0 17 43.7±2.8 56 73
Data shown are the average of at least three different experiments. Wild-type cells were grown in modified M9 medium as described in “Materials
and methods”. Cultures were induced with 0.1 mM IPTG, and at the same time, 2-ketobutyrate was added to a final concentration of 8 g/L.
Samples were taken 16 h after induction.
a Conversion given as molar conversion from the 2-ketobutyrate added at induction
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expressed from pSA55 is able to decarboxylate a broad
range of 2-ketoacids (de la Plaza et al. 2004; Atsumi et al.
2008), the KDC and AHAS would compete for 2KB in the
cell. If KDC outcompetes AHAS for 2KB, 1-propanol will
be produced instead of 2MB. To test the selectivity, we
added 0.8% w/v 2KB to the production medium and
measured 2MB and 1-propanol production.
The AHAS II from S. typhimurium produced the highest
amount of 2MB and is the only AHAS that led to higher
selectivity of 2MB production versus 1-propanol. AHAS III
from E. coli also produced a significant amount of 2MB,
but could not outcompete KDC for 2KB, thus 1-propanol
production was even higher. While AHAS I is used in
isoleucine production in C. glutamicum, this isozyme did
not fare well in 2MB production in E. coli, though it
performed much better than the AHAS I from E. coli. The
conversion rate of 2KB to 2MB is very low for E. coli
AHAS I compared to the other isozymes. Since this enzyme
is a poor consumer of 2KB, the high 2KB concentration
became poisonous to the cells (LaRossa and Van Dyk
Table 2 Strains and plasmids used in this study
Name Relevant genotype Reference
Strains
BW25113 rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78 Datsenko and Wanner (2000)
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′
proAB lacIqZΔM15 Tn10 (TetR)]
Stratagene
CRS22 BW25113 F′ ΔmetA Δtdh Shen and Liao (2008)
CRS24 BW25113 F′ ΔmetA Δtdh ΔilvB ΔilvI Shen and Liao (2008)
CRS38 BW25113 F′ ΔmetA Δtdh ΔilvB ΔilvI ΔleuABCD This study
AFC16 BW25113 F′ ΔmetA Δtdh ΔleuA This study
AFC18 BW25113 F′ ΔmetA Δtdh ΔleuA ΔilvE This study
Plasmids
pSA40 ColE1 ori, AmpR, PLlacO1::MCS Atsumi et al. (2008)
pSA54 p15A ori, KanR, PLlacO1::ilvIHCD Atsumi et al. (2008)
pSA55 ColE1 ori, AmpR, PLlacO1::kivd ADH2 Atsumi et al. (2008)
pKS15 p15A ori, KanR, PLlacO1::ilvBNCD (from E. coli) This study
pCS49 From pSA40, pSC101 ori, SpecR, PLlacO1::thrABC from E. coli Shen and Liao (2008)
pAFC3 p15A ori, KanR, PLlacO1::ilvGMCD (ilvGM from S. typhimurium) This study
pAFC8 pSA55 with tdcB from E. coli in XbaI cut site This study
pAFC23 p15A ori, KanR, PLlacO1::ilvGMCD (from E. coli) This study
pAFC26 p15A ori, KanR, PLlacO1::ilvBNCD (ilvBN from C. glutamicum) This study
pAFC29 p15A ori, KanR, PLlacO1::ilvGMCD (ilvGM from K. pneumoniae) This study
pAFC45 pSA55 with ilvA from E. coli in XbaI cut site This study
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1987). Not only does S. typhimurium AHAS II outcompete
the KDC for 2KB, but it also outperforms other competing
enzymes for 2KB consumption, making this enzyme the
clear favorite among those tested here.
Selection of threonine deaminase
After the AHAS enzyme, the next important enzyme
target for overexpression is the threonine deaminase. As
shown previously, threonine deaminase overexpression
effectively draws carbon flux towards the isoleucine
pathway (Morbach et al. 1996). In E. coli, there exists
both a biosynthetic (encoded by ilvA) and a catabolic
(encoded by tdcB) threonine deaminase. The biosynthetic
deaminase is susceptible to feedback inhibition by isoleu-
cine (Umbarger 1956), while the catabolic deaminase is
not, though it can be inhibited by high 2KB concentrations
(Shizuta et al. 1973). We also compared ilvA from C.
glutamicum, though it, too, is inhibited by isoleucine
(Möckel et al. 1992).
In a similar fashion as the AHAS comparison, to test
these threonine deaminases we inserted each of the three
genes into pSA55 in a cassette fashion. As a control we
used pSA55, which contains no threonine deaminase gene,
and compared this to the effect of the overexpression of
threonine deaminase. We then combined these plasmids
with pAFC3, containing the genes encoding S. typhimurium
AHAS II as determined from the previous experiment, in
the same BW25113 host background. We added 0.8% w/v
L-threonine to the production medium to study the
efficiency of L-threonine deamination by the various
isozymes and measured the alcohol production profiles in
each case (Fig. 2).
Overexpression of each of the threonine deaminase
isozymes results in a greater conversion of L-threonine to
2MB and 1-propanol compared to chromosomal deaminase
activity. This is in agreement with previous data suggesting
greater isoleucine production with overexpression of thre-
onine deaminase. The increased expression of E. coli
biosynthetic deaminase (ilvA) only increased conversion
from about 38% to about 45%, while increasing expression
of the catabolic deaminase from E. coli (tdcB) converted
62% of the supplied L-threonine. However, the best
isozyme tested was the C. glutamicum threonine deami-
nase, the overexpression of which converted nearly 88% of
the supplied L-threonine to 2MB and 1-propanol.
Overproduction of the threonine pathway
One further part of the pathway that would be important to
amplify is the formation of threonine from OAA. This
transformation occurs in six enzymatic reactions, but
previous results (Morbach et al. 1996) indicate that the
steps governed by thrA and thrB are the most important.
The products of these two genes lie at important branch
points in the aspartate family of amino acids (Fig. 1), with
thrA drawing carbon flux away from lysine production and
thrB drawing carbon flux away from methionine. The thrA
gene product also catalyzes the first step in the conversion
of aspartate to isoleucine. In E. coli, thrABC is situated in
one operon and so we cloned this operon into a low copy
number vector in pCS49, removing the native transcription
attenuation. Combined with the plasmids determined in the
earlier experiments, pAFC46 (KDC, ADH, threonine
deaminase) and pAFC3 (AHAS II, ilvCD), we performed
16-h production experiments comparing the effect of
adding this threonine operon on 2MB production in
(Fig. 3).
In wild-type background with only chromosomal ex-
pression of thrABC, isobutanol is the major product, as
there is not enough 2KB being produced for sufficient 2MB
production. Addition of the threonine operon plasmid
doubles the 2MB production from 5.5 to 11 mM, while
nearly cutting isobutanol production in half from 21 to
11.5 mM. The formation of 1-propanol also triples from 1.9
to 5.8 mM, which though in itself is not desirable, shows
that much more 2KB is being generated in the cultures. In
fact, the decrease in isobutanol (9.5 mM) is almost entirely
accounted for in the increase of both 2MB and 1-propanol
(9.4 mM), indicating that the effect of thrABC over-


























Fig. 2 Comparison of threonine deaminase efficiency in 2MB
production. Wild-type cells expressing pAFC3 and either pSA55 (no
deaminase overexpression), pAFC8 (E. coli tdcB), pAFC45 (E. coli
ilvA), or pAFC46 (C. glutamicum ilvA) were supplied with 8 g/L L-
threonine. Samples were taken 16 h after induction. Conversion is
given as molar conversion from the supplied L-threonine. Data shown
are the average of at least three independent experiments
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Gene deletion to attenuate product specificity
Upon determining a useful set of enzymes for over-
expression to boost 2MB production, we looked to gene
knockouts to further increase 2MB production and yield
while reducing side product formation. The first two
knockouts upstream of 2KB production, ΔmetA, for
elimination of carbon flux to methionine production, which
diverts the flux away from threonine, and Δtdh, for
reduction of competing threonine consumption, are directed
at improving the carbon flux towards 2KB. From this
double knockout strain we took two paths towards reducing
the alcohol side products made. The first path involved
removing the competing native AHAS isozymes that
contribute to isobutanol formation, and these are encoded
by ilvI and ilvB. The second approach began with
eliminating the two peripheral side products, 1-butanol
and 3-methyl-1-butanol, by deletion of leuA, which encodes
the enzyme catalyzing the first committed step in the
formation of these two alcohols. This strain was further
engineered by removing ilvE in the hopes of reducing the
amount of isoleucine created from the KMV produced. The
full results of these gene knockouts are shown in Fig. 4.
Each strain shown in Fig. 4 contains the three plasmids
(pAFC3, pAFC46, pCS49) expressing all the genes that we
determined were beneficial to 2MB production.
The strain with the highest 2MB production is the
ΔmetA Δtdh double knockout strain, CRS22. It seems that
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bFig. 4 Effect of gene knockoutcombinations on 2-methyl-1-bu-
tanol production. Wild-type
cells and strains CRS22 (ΔmetA
Δtdh), CRS24 (ΔmetA Δtdh
ΔilvBI), CRS38 (ΔmetA Δtdh
ΔilvBI ΔleuABCD), AFC16
(ΔmetA Δtdh ΔleuA), and
AFC18 (ΔmetA Δtdh ΔleuA
ΔilvE) expressing pAFC3,
pAFC46, and pCS49 are shown.
Data shown are the average of at
least three independent experi-
ments. a 2MB production. b
Isobutanol production. c 1-
Propanol production. d Glucose
















Fig. 3 Effect of thr operon overexpression on 2-methyl-1-butanol
production. Wild-type cells expressing pAFC3 and pAFC46 with and
without pCS49 (thrABC) are shown. Samples were taken 16 h after
induction. Data shown are the average of at least three independent
experiments
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in 2KB produced as measured by the production of 2MB
and 1-propanol. Using this metric, nearly 24 mM 2KB is
converted to 2MB and 1-propanol in CRS22 as compared
to only 14.5 mM in wild-type. However, much of that extra
2KB goes towards 1-propanol production as 2MB increases
from 11.2 to 14.2 mM while 1-propanol increases from 3.2
to 9.6 mM.
As for additional gene deletions, the most noticeable
difference is in the diverse alcohol production profiles.
From strain CRS22, further deletion of ilvB and ilvI to
make CRS24 eliminates the competing AHAS enzymes
that contribute more to valine production than to isoleucine.
While isobutanol production is reduced by one third, 2MB
production is also slightly reduced by about 15% by the
loss of these additional AHAS enzymes. However, CRS24
converts the same amount of total 2KB (24 mM) compared
to CRS22, as the 1-propanol production rises by exactly the
amount of lost 2MB. The leuABCD operon was then
removed from CRS24 to make CRS38 in order to
completely remove 1-butanol and 3-methyl-1-butanol pro-
duction. While CRS38 produces a better ratio of 2MB to
isobutanol and 1-propanol than the other strains tested, it
also suffers from a lower overall production compared to
the other strains with a much slower growth rate, and so is
not clearly better than the others.
The other string of knockout strains began by deleting
leuA directly from the double knockout CRS22 (ΔmetA
Δtdh) to make AFC16 for a cleaner product profile and
reduce consumption of 2KB for 1-butanol production.
Unfortunately, the major effect noticed was lower total cell
density compared with the parent strain. While less severe
than CRS38, it seems that the deletion of leuA has some
adverse effect on growth when combined with the plasmids
used in our system. Deletion of leuA also removed all traces
of 1-butanol and 3-methyl-1-butanol, but again this appar-
ently did little for the production of the other alcohols.
Despite these considerations, this strain converted about the
same amount of 2KB (23 mM) as its parent CRS22 and
also CRS24, suggesting that increasing the 2KB levels
further is more important for producing more 2MB than
knocking out these side product pathways. Continuing from
AFC16, we next made AFC18 by removing ilvE, which
encodes the branched-chain amino acid aminotransferase,
looking to increase 2MB production by reducing the
amount of isoleucine created from the KMV produced.
Strangely, this deletion actually reduced 2MB somewhat
but made little difference in 1-propanol and isobutanol
production. It was thought that this knockout would
particularly benefit 2MB due to the low KM value that this
aminotransferase has for KMV (Lee-Peng et al. 1979), but
this was not the case. The leuA and ilvE knockouts do not
seem to provide much benefit to 2MB production, contrary
to what we thought would be the case.
To take a closer look at the production profile of 2MB
and related alcohol byproducts, a more detailed time course
was obtained of the wt strain and CRS22 (ΔmetA Δtdh),
both containing production plasmids pAFC3, pAFC46, and
pCS49 (Fig. 5). From this figure, it becomes more obvious
that production of 2MB is closely tied to the growth phase.
Formation of 1-propanol develops as the 2MB production
slows, and this negatively impacts 2MB yields.
Discussion
We successfully engineered the first strain of E. coli to
produce the fuel alcohol 2MB to a final level of 1.25 g/L in
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Fig. 5 Detailed time course of strains containing the three production plasmids pAFC3, pAFC46, and pCS49. a BW25113 wt strain. b CRS22
(ΔmetA Δtdh) strain
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of up to 0.17 g 2MB per gram glucose, which is 44% of the
maximum theoretical yield. Much of the success of
producing 2MB is due to the use of the host’s native
isoleucine biosynthetic pathway to synthesize KMV, the 2-
ketoacid precursor of both isoleucine and 2MB. Earlier
work in producing isoleucine from glucose in E. coli has
produced yields of up to 0.25 g/g (Hashiguchi et al. 1999),
or 0.35 mol/mol. This is similar to what our strains CRS22
(0.32 mol/mol), CRS24 (0.35 mol/mol), and AFC16
(0.34 mol/mol) achieve during the growth phase before 1-
propanol production becomes prominent. It turns out that
both isoleucine and 2MB share a maximum theoretical
yield of 0.8 mol/mol glucose, so we can compare these
molar yields head to head.
While our efforts in producing 2MB were aided by
previous work in isoleucine production due to an overlap in
their biosynthetic pathways, it is important to recognize the
unique challenges involved in 2MB production. The first
challenge comes from the bifurcated pathway from glucose
to 2MB, and the need for the two precursors, pyruvate and
2KB, to be balanced for efficient 2MB production (Fig. 1).
Furthermore, both of these necessary precursors lead
directly to an unavoidable alcohol side product, with 2KB
leading to 1-propanol formation and pyruvate leading to
isobutanol formation. Additionally, each of these alcohols is
toxic to the host even at fairly low levels, with 2MB in
particular affecting E. coli growth rate at concentrations as
low as 1 g/L (data not shown).
To illustrate the difference in the biosynthesis of
isoleucine and 2MB, the data in Fig. 2 suggest that
feedback inhibition due to isoleucine is not an issue for
2MB production. In fact, ilvA from C. glutamicum
produced the best in terms of 2MB despite its inhibition
by isoleucine. It has also been reported that in isoleucine
production, tdcB from E. coli can produce as much as ten-
fold better than ilvA from C. glutamicum in a C.
glutamicum strain (Guillouet et al. 1999), and we clearly
did not see that effect here. This information serves to
highlight one aspect of how much 2MB production differs
from isoleucine production.
The ultimate goal is to produce higher alcohol biofuels
such as 2MB directly from plant biomass, including
cellulose and hemicellulose. First, the production of 2MB
must be improved by reducing the alcohol side products,
especially the 1-propanol production that becomes promi-
nent after the growth phase. At first glance, it seems this is
just another obstacle for metabolic engineering to over-
come; however, 1-propanol and isobutanol are formed
using the KDC and ADH necessary for 2MB production,
and isobutanol production is also aided by overexpression
of the AHAS enzyme. From this, it becomes apparent that
simple metabolic engineering strategy can do only so much
to reduce these side products. Since this becomes an issue
of substrate competition with both AHAS and KDC, a
protein engineering approach appears necessary.
In this first attempt at production of 2MB from a
renewable feedstock, the main challenge addressed was
that of precursor balancing. Due to the central role of
pyruvate in glucose metabolism, we focused instead on
increasing the availability of 2KB for efficient 2MB
biosynthesis. This was accomplished by overexpressing
key genes in the threonine biosynthetic pathway (thrABC)
without native transcription regulation and also over-
expressing an efficient threonine deaminase to convert the
increased threonine to 2KB. Further improvement was
obtained by knocking out the competing pathways up-
stream of 2KB production (ΔmetA, Δtdh). Combined with
the overexpression of the downstream part of isoleucine
biosynthesis (ilvGMCD), along with the KDC and ADH
necessary for conversion of KMV to 2MB, this strategy
worked to achieve 1.25 g/L 2MB produced in 24 h.
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